Rohan Palekar, SVP & Chief Commercial Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), bought 10,000 shares at $2.80 ($28K) on 2013-12-17, disclosed to the SEC on 2013-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ETNB | SELL | 2024-04-03 | $1.2M | — | Filing → |
| ETNB | SELL | 2024-02-28 | $48K | — | Filing → |
| ETNB | SELL | 2024-01-03 | $560K | — | Filing → |